Kidney Research and Clinical Practice

Author index

Page Path

HOME
BROWSE ARTICLES
Author index

Dae Ryong Cha	14 Articles
Special Articles Kidney Health Plan 2033 in Korea: bridging the gap between the present and the future Do Hyoung Kim, Young Youl Hyun, Jin Joo Cha et al. Kidney Res Clin Pract. 2024;43(1):8-19. Published online January 31, 2024 DOI: https://doi.org/10.23876/j.krcp.23.232 Web of Science 1 Cited By 1 Full text PubReader ePub PDF Review Articles Adenosine receptors as emerging therapeutic targets for diabetic kidney disease Eun Seon Pak, Jin Joo Cha, Dae Ryong Cha, Keizo Kanasaki, Hunjoo Ha Kidney Res Clin Pract. 2022;41(Suppl 2):S74-S88. Published online August 22, 2022 DOI: https://doi.org/10.23876/j.krcp.22.011 Web of Science 3 Cited By 3 Full text PubReader ePub PDF Editorial Diabetic kidney disease, revisited: where do we stand? Dae Ryong Cha Kidney Res Clin Pract. 2022;41(Suppl 2):S31-S32. Published online September 30, 2022 DOI: https://doi.org/10.23876/j.krcp.22.002 Full text PubReader ePub PDF Original Articles Serum interferon-γ and urinary monocyte chemoattractant peptide-1 are important factors in the pathogenesis of immunoglobulin A nephropathy Sang Youb Han, Kyung Hwan Jeong, Chun-Gyoo Ihm, Young Sun Kang, Dae Ryong Cha Kidney Res Clin Pract. 2021;40(1):69-76. Published online March 12, 2021 DOI: https://doi.org/10.23876/j.krcp.20.157 Web of Science 4 Cited By 4 Full text PubReader ePub PDF Supplementary Material Editorials Mineralocorticoid receptor blockade for renoprotection Dae Ryong Cha Kidney Res Clin Pract. 2018;37(3):183-184. Published online September 30, 2018 DOI: https://doi.org/10.23876/j.krcp.2018.37.3.183 Web of Science 1 Cited By 1 Full text PubReader PDF Corrigendum Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea [Volume 36, Issue 1, March 2017, Pag Ran-hui Cha, Shin Wook Kang, Cheol Whee Park et al. Kidney Res Clin Pract. 2018;37(1):98-99. Published online March 31, 2018 DOI: https://doi.org/10.23876/j.krcp.2018.37.1.98 Full text PubReader PDF Original Articles Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea Ran-hui Cha, Shin Wook Kang, Cheol Whee Park et al. Kidney Res Clin Pract. 2017;36(1):68-78. Published online March 31, 2017 DOI: https://doi.org/10.23876/j.krcp.2017.36.1.68 Web of Science 33 Cited By 31 Full text PubReader PDF Supplementary Material Editorial Interleukin-6 signaling in podocyte hypertrophy Dae Ryong Cha Kidney Res Clin Pract. 2016;35(4):195-196. Published online October 12, 2016 DOI: https://doi.org/10.1016/j.krcp.2016.10.001 Web of Science 2 Cited By 1 Full text PubReader PDF Corrigendum Effects of Toll-like receptor antagonist 4,5-dihydro-3-phenyl-5-isoxasole acetic acid on the progression of kidney disease in mice on a high-fat diet [Volume 33, Issue 1, March 2014, Pages 33–44] Hye Sook Min, Jung Eun Kim, Mi Hwa Lee et al. Kidney Res Clin Pract. 2015;34(1):66-66. Published online April 1, 2015 DOI: https://doi.org/10.1016/j.krcp.2015.03.002 Full text PubReader PDF Case Reports A case of primary aldosteronism combined with acquired nephrogenic diabetes insipidus Kitae Kim, Jae Hyoung Lee, Sun Chul Kim, Dae Ryong Cha, Young Sun Kang Kidney Res Clin Pract. 2014;33(4):229-233. Published online November 26, 2014 DOI: https://doi.org/10.1016/j.krcp.2014.09.001 Web of Science 2 Cited By 3 Full text PubReader PDF Original Articles Effects of Toll-like receptor antagonist 4,5-dihydro-3-phenyl-5-isoxasole acetic acid on the progression of kidney disease in mice on a high-fat diet Hye Sook Min, Jung Eun Kim, Mi Hwa Lee et al. Kidney Res Clin Pract. 2014;33(1):33-44. Published online January 11, 2014 DOI: https://doi.org/10.1016/j.krcp.2013.11.002 Web of Science 19 Cited By 17 Full text PubReader PDF Serum calcium and phosphorus levels in patients undergoing maintenance hemodialysis: A multicentre study in Korea Gheun-Ho Kim, Bum Soon Choi, Dae Ryong Cha et al. Kidney Res Clin Pract. 2014;33(1):52-57. Published online February 21, 2014 DOI: https://doi.org/10.1016/j.krcp.2013.12.003 Web of Science 19 Cited By 20 Full text PubReader PDF Plasma leptin concentrations are greater in type II diabetic patients and stimulate monocyte chemotactic peptide-1 synthesis via the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway Jin Joo Cha, Young Youl Hyun, Yi Hwa Jee et al. Kidney Res Clin Pract. 2012;31(3):177-185. Published online June 26, 2012 DOI: https://doi.org/10.1016/j.krcp.2012.06.004 Cited By 6 Full text PubReader PDF Pan-Nox inhibitor treatment improves renal function in aging murine diabetic kidneys Jeong Hoon Park, Sung Gi Yoon, Jung Yeon Ghee et al. Received January 4, 2023 Accepted April 22, 2023 Published online August 10, 2023 [Epub ahead of print] Cited By 1 Full text PubReader ePub PDF
Dae Ryong Cha	1 Article
Editorial Where do we stand on human diabetic nephropathy? Dae Ryong Cha Kidney Res Clin Pract. 2013;32(3):93-95. Published online August 31, 2013 DOI: https://doi.org/10.1016/j.krcp.2013.07.007 Cited By 3 Full text PubReader PDF

Volume 43, No. 2

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.0

MOST VIEWED MOST CITED

14,870	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
19,835	C4d Puzzle in ABO-incompatible kidney transplantation
8,296	How should we treat acute kidney injury caused by renal congestion?
13,021	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
35,046	Uremic pruritus: pathophysiology, clinical presentation, and treatments

Cited By 14	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2024 by The Korean Society of Nephrology.